AlloVir Securities Corporation

AMAG Pharmaceuticals is a biopharmaceutical company that utilizes its proprietary nanoparticle technology for the development and commercialization of therapeutic iron compounds to treat anemia and novel imaging agents to aid in the diagnosis of cancer and cardiovascular disease. The company has two commercial products, Feridex I.V. and GastroMARK, both of which are imaging agents that are approved and marketed in the United States, Europe and other countries. Ferumoxytol, the company's key product candidate, is being developed for use as an intravenous iron replacement therapeutic for the treatment of iron deficiency anemia in chronic kidney disease. Combidex, the company's other product under development, is an investigational functional molecular imaging agent consisting of iron oxide nanoparticles for use in conjunction with magnetic resonance imaging (MRI) to aid in the differentiation of cancerous from normal lymph nodes. AMAG Pharmaceuticals corporate and executive offices are located in Cambridge, Mass.

Invivyd, Inc., located in Waltham, MA, is at the forefront of developing innovative medicines aimed at tackling serious infectious diseases. Their proprietary technology platform enables the creation of potent antibodies that are more resilient to viral evolution, positioning them as a leader in the industry. Collaborating with notable figures such as pro football coach Jim Harbaugh, Invivyd seeks to raise awareness about the ongoing impact of COVID-19 while advancing a robust pipeline of monoclonal antibody candidates. Their commitment to protecting vulnerable populations from current and future viral threats underscores their mission-driven approach to healthcare innovation. Generated from the website

Taris Bio Medical in Lexington is at the forefront of cancer interception research, aiming to eliminate cancer by understanding the transformation of healthy cells into cancerous ones. Through innovative approaches, their team is focused on identifying pre-malignant cells to develop targeted treatments that can halt the progression of cancer before it becomes more aggressive and resistant to traditional therapies. Generated from their website's infomation